News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Discover Latest #Financial support News, Articles and Videos with Contenting
1. "Fintech Funding Hits Record High in 2020, Thanks to Coronavirus Stimulus" - CNBC, December 28, 2020 https://www.cnbc.com/2020/12/28/fintech-funding-hits-record-high-in-2020-thanks-to-coronavirus-stimulus.html 2. "These Are the Government Programs That Can Provide Financial Support to Small Businesses During the Coronavirus Crisis" - Forbes, April 3, 2020 https://www.forbes.com/sites/alexkonrad/2020/04/03/these-are-the-government-programs-that-can-provide-financial-support-to-small-businesses-during-the-coronavirus-crisis/ 3. "Coronavirus: What is the Job Support Scheme and how do I claim financial support?" - The Independent, October 13, 2020 https://www.independent.co.uk/money/coronavirus-job-support-scheme-claim-furlough-self-employed-a9670096.html 4
New Clinical Data on BellaSeno’s Novel, Resorbable Breast Implants Presented at The Aesthetic MEET 2025 - ForexTV
Presentation by Prof. Anand Deva highlights 87% breast volume retention and low complication rate in one-year patient follow-upSuccessful vascularization and vessel formation in two-year follow-up 3D-printed resorbable scaffold to preserve both volume and shape of autologous fat in the medium to long term Leipzig, Germany / Brisbane, Australia, March 24, 2025 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, today announced that Prof. Anand Deva presented new clinical data on BellaSeno’s novel, 3D-printed, resorbable breast scaffolds at The Aesthetic MEET 2025 conference in Austin, TX, USA. In an Australian clinical trial initiated in 2022, 19 patients received BellaSeno’s resorbable, polycaprolactone-based breast scaffolds following removal of failed silicone breast implants. The results at one-year follow-up examination showed 87% breast volume retention, low complication rates, high quality of life, a natural softness, and improvements in physical and psychological wellbeing. Moreover, none of the complications associated with silicone implants or fat grafting (e.g., capsular contractures, infections, necrosis, calcification, oil cysts, or scaffold removals) were recorded. For patients reaching the two-year mark, Prof. Deva and his team observed successful vascularization and vessel network formation in the newly formed breast tissue within the scaffold. “These clinical findings demonstrate that BellaSeno has developed a safe, high-performance alternative to silicone breast implants,” said Prof. Deva. “BellaSeno’s implants enhance and protect the body’s own regenerative potential, replacing and/or augmenting like tissue with like tissue.” “This is another milestone demonstrating that our pioneering approach offers a risk-optimized, high-quality solution for patients who have experienced complications related to silicone breast implants, promising them a natural alternative,” said Mohit Chhaya, CEO of BellaSeno. “Pleasingly, our scaffolds enabled the breasts to maintain their shape, volume and form over time and achieved softness, another crucial performance measure.” Professor Anand Deva is the Discipline head of Cosmetic, Plastic and Reconstructive Surgery at Macquarie University, Australia, and founder of Integrated Breast Health Clinics through partnership with government and industry. He is committed to scientific innovation and translational research with the aim of improving clinical practice and outcomes for patients. ### About BellaSenoBellaSeno GmbH was founded in 2015 and is headquartered on the BioCity campus in Leipzig, Germany, with a subsidiary in Brisbane, Australia. The Company is developing novel resorbable soft tissue and bone reconstruction implants made by additive manufacturing (3D-printing) under ISO 13485 certification. The Company has received substantial financial support from private investors as well as from the Saxony Development Bank (SAB), the European Fund for Regional Development (EFRE), Germany´s Federal Ministry of Education and Research (BMBF) and the Australian government. The Company has been co-funded from tax resources based on the budget adopted by the members of Saxony State Parliament. Contact BellaSenoBellaSeno GmbHDr. Mohit Chhayamohit.chhaya@bellaseno.comTel.: +49 176 2283 9583 Media InquiriesakampionDr. Ludger Wess / Ines-Regina Buth Managing Partnersinfo@akampion.comTel. +49 40 88 16 59 64Tel. +49 30 23 63 27 68
ACEN Australia secures A$750-M loan for energy projects - BusinessWorld Online
AYALA-LED ACEN Corp. said its subsidiary ACEN Australia Pty. Ltd. has secured an A$750-million loan from various financial institutions, which will allow it to fund its energy projects in Australia. Eleven Australian and international lenders backed the transaction, providing ACEN Australia with financial support for its pipeline projects, the company said in a stock exchange […]
Tesla Stock Has Crashed 50% and Investors Just Got Bad News From One of Wall Street's Biggest Bulls
At the time, Donald Trump had just won the presidential election with tremendous financial support from CEO Elon Musk, and investors were confident the company would benefit from their relationship. Tesla stock has plummeted 50% from its record high and market share losses have accelerated as Musk's involvement in politics has created a "brand crisis" for the company, according to equity analyst Dan Ives at Wedbush Securities.
DoF: PHL vulnerability warrants more financial support from multilaterals - BusinessWorld Online
By Luisa Maria Jacinta C. Jocson, Senior Reporter MILAN, Italy — The Philippines will still need financing assistance due to its exposure to shocks like climate risks and even as it graduates to upper middle-income status, the Department of Finance (DoF) said, urging the Asian Development Bank (ADB) to continue expanding its support to the […]